Marked response to nivolumab combined with external radiation therapy for metastatic renal cell carc...
Marked response to nivolumab combined with external radiation therapy for metastatic renal cell carcinoma: report of two cases
About this item
Full title
Author / Creator
Publisher
Tokyo: Springer Japan
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: Springer Japan
Subjects
More information
Scope and Contents
Contents
Although nivolumab has been regarded as a standard agent for patients with previously treated advanced renal cell carcinoma (RCC), a significant proportion of these patients fail to achieve a response to nivolumab. In recent years, several studies have reported the favorable therapeutic impact of combined therapy with immune checkpoint inhibitors a...
Alternative Titles
Full title
Marked response to nivolumab combined with external radiation therapy for metastatic renal cell carcinoma: report of two cases
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6498363
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6498363
Other Identifiers
ISSN
2192-3183
E-ISSN
2192-3183
DOI
10.1007/s13691-018-0349-7
